Delivery Order SPE2DB22D9316-SPE2DB24FYP13

Award Date 5/7/24
Potential Completion Date 5/8/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,565,106,523 units of the prescription drug Jakafi 15 mg tablet. This order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,849.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order contract, which is not associated with any set-aside designation, is for the provision of JAKAFI 5 MG TABLET 60S, with a period of performance through November 21, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $23,547.74 contract provides the DLA with 60 tablets of the 15 mg dosage of the prescription drug JAKAFI. This delivery order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract, valued at up to $4,999,999, that enables the DLA to issue delivery orders for a broad range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,794.12 contract is for the delivery of JAKAFI 20 MG TABLET 60S, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program, which covers a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,794.12, is for the delivery of JAKAFI 20 MG TABLET 60S, a specialized pharmaceutical product. The delivery order was awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,794.12 firm fixed-price delivery order is for the supply of JAKAFI 20 MG TABLET 60S, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that runs through December 31, 2025. This single-award IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $23,614.86 contract is for the supply of JAKAFI 25 MG TABLET 60S, a pharmaceutical product. This delivery order was issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB24FPQE6 with DLA, which has a ceiling value of up to $4,999,999 and provides for a broad range of...
This is a federal contract award by the Defense Logistics Agency (DLA) under its Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $35,521.98, is for the delivery of 4,564,491,839 tablets of the prescription drug JAKAFI 10 MG to support the recurring medical supply needs of military health facilities. The contract is a delivery order under a broader indefinite delivery contract (IDC) valued at up to...
This contract award, valued at $11,840.66, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP13
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,794.12, is for the delivery of 4,564,536,826 units of the prescription drug JAKAFI 20 MG TABLET 60S. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999 and running through December 31, 2025, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support military medical facilities worldwide. This contract does not have a set-aside designation.

Generated 8/6/24, 10:54 AM